MDVIP was founded in 2000 with a vision for a better way to practice medicine and to provide level of care that patients deserve. Since its founding, the company has been at the forefront of affordable, personalized healthcare; MDVIP-affiliated physicians limit the size of their practices, allowing each physician to spend more time with patients than in a traditional practice model. Summit first invested in MDVIP in 2004 and held a minority interest in the company until its acquisition by Proctor & Gamble in 2009. By 2014, P&G sought to divest the business. Summit’s familiarity with the company and the market created an opportunity to partner again with MDVIP to help the company accelerate its growth and further establish its leadership position in the concierge medicine market.

How Summit helped:

• Led a majority recapitalization in 2014 and re-introduced Bret Jorgensen, former MDVIP CEO from 2008-2009, as Executive Chairman. Bret subsequently became CEO again in late 2014 and continues to lead the company today.
• Worked closely with MDVIP management to grow the patient base, expand and optimize the physician network and develop new product lines
• Engaged Summit’s Peak Performance Group to help create a proprietary statistical model aimed at improving patient conversion rates to newly affiliated practices
• Summit’s Peak Performance Group also collaborated with management in developing a segmentation model aimed at assisting the sales team in targeting physicians with the highest likelihood of successfully transitioning their practice to the MDVIP model

In 2017, MDVIP continued to lead the U.S. market for membership-based medicine with more than 850 MDVIP-affiliated primary care physicians serving more than 280,000 members and a consistent member retention rate of more than 90%. Through its highly individualized care model and emphasis on prevention and wellness, MDVIP continues to execute on its mission to innovate and improve the delivery of primary care.